Marcus Sucksdorff
1 of 2
- Integrating TSPO-PET imaging with metabolomics for enhanced prognostic accuracy in multiple sclerosis (2025)
- BMJ neurology open
- P2X 7-receptor binding in new-onset and secondary progressive MS – a [11C]SMW139 PET study (2024)
- EJNMMI Research
- Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy (2024)
- European Journal of Clinical Microbiology and Infectious Diseases
- Smouldering Inflammation in Multiple Sclerosis – A PET Imaging Study on Prediction of Disease Progression and Effects of Treatment (2024) Sucksdorff Marcus
- Association of serum neurofilament light with microglial activation in multiple sclerosis (2023)
- Journal of Neurology, Neurosurgery and Psychiatry
- Early prognosticators of later TSPO-PET-measurable microglial activation in multiple sclerosis (2023)
- Multiple Sclerosis and Related Disorders
- Longitudinal stability of progression-related microglial activity during teriflunomide treatment in patients with multiple sclerosis (2023)
- European Journal of Neurology
- PET-measurable innate immune cell activation reduction in chronic active lesions in PPMS brain after rituximab treatment: a case report (2023)
- Journal of Neurology
- TSPO-Detectable Chronic Active Lesions Predict Disease Progression in Multiple Sclerosis (2023)
- Neurology, Neuroimmunology and Neuroinflammation
- Association between microglial activation and serum kynurenine pathway metabolites in multiple sclerosis patients (2022)
- Multiple Sclerosis and Related Disorders
- Innate Immune Cell-Related Pathology in the Thalamus Signals a Risk for Disability Progression in Multiple Sclerosis (2022)
- Neurology, Neuroimmunology and Neuroinflammation
- MS-taudin varhainen ja tehokas hoito kannattaa (2022)
- Erikoislääkäri
- Phenotyping of multiple sclerosis lesions according to innate immune cell activation using TSPO-PET (2022)
- Brain Communications
- Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot study (2021)
- Multiple Sclerosis and Related Disorders
- High serum neurofilament associates with diffuse white matter damage in MS (2021)
- Neurology, Neuroimmunology and Neuroinflammation
- Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis: GFAP and DTI (2021)
- Multiple Sclerosis and Related Disorders
- Whole Brain Adiabatic T-1rho and Relaxation Along a Fictitious Field Imaging in Healthy Volunteers and Patients With Multiple Sclerosis: Initial Findings (2021)
- Journal of Magnetic Resonance Imaging
- Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis (2020)
- Brain
- Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging (2020)
- Neurology, Neuroimmunology and Neuroinflammation
- Rituximab in the treatment of multiple sclerosis in the Hospital District of Southwest Finland (2020)
- Multiple Sclerosis and Related Disorders
UTU Research Portal